A precision application approach for biopesticides targeting Zymoseptoria tritici in wheat, combining spore trapping and rapid molecular diagnostics to time sprays during pathogen germination. Validated through on-farm trials over four years, this method aims to reduce variable efficacy and high costs that currently limit biopesticide adoption in arable crops.
Septoria leaf blotch, caused by Zymoseptoria tritici, is one of the most economically damaging diseases of wheat in the UK and across Europe. Biopesticides represent the fastest-growing segment of crop protection globally, yet their adoption in arable farming remains constrained by inconsistent efficacy, lack of residual activity, and high application costs. This project addresses those barriers by shifting biopesticide use from undirected, calendar-based spraying to precision-timed applications driven by real-time pathogen monitoring.
The core value proposition is straightforward: if growers can detect when Z. tritici spores are landing on the leaf surface and confirm that conditions are conducive for germination, biopesticides such as Serenade can be deployed at the moment they are most effective. By integrating spore trapping with rapid molecular detection and environmental forecasting, the approach promises more reliable disease control, reduced fungicide inputs, and lower overall spray programme costs.
Core approach:
Trial design (NU Farms commercial wheat platform):
Partnership requirements:
The programme is grounded in four years of on-farm trial evidence demonstrating that biopesticide-inclusive fungicide programmes can deliver Septoria control comparable to conventional sprays, although results have been variable by site and season. Current work focuses on optimising timing and integration strategies through controlled comparison on a commercial wheat platform at NU Farms. The system is at field-validation stage (TRL 6–7), with the next milestone being demonstration that precision-timed biopesticide applications consistently outperform undirected applications in efficacy and cost-effectiveness across multiple seasons.
Newcastle University is a comprehensive public research university in Newcastle upon Tyne, with broad academic and translational activity. Its city‑centre Newcastle Helix innovation district—developed with Newcastle City Council and Legal & General—co‑locates researchers with companies and hosts national innovation centres to enable fast collaboration. Deep integration with Newcastle upon Tyne Hospitals NHS Foundation Trust, supported by a joint research office, enables streamlined study setup, access to clinical populations, and end‑to‑end clinical translation. Research is backed by competitive funding from UKRI councils, the National Institute for Health and Care Research, major charities, the European Union, and industry. A dedicated technology transfer office supports IP, licensing, spinouts, and knowledge‑transfer partnerships.